Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Tropoxane

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
Tropoxane
Clinical data
ATC code
  • none
Identifiers
  • Methyl (1R,2S,3S,5S)-3-(3,4-dichlorophenyl)-8-oxabicyclo[3.2.1]octane-2-carboxylate
CAS Number
PubChemCID
ChemSpider
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC15H16Cl2O3
Molar mass315.19 g·mol−1
3D model (JSmol)
  • Clc1ccc(cc1Cl)[C@H]2C[C@H]3O[C@@H]([C@H]2C(=O)OC)CC3
  • InChI=1S/C15H16Cl2O3/c1-19-15(18)14-10(7-9-3-5-13(14)20-9)8-2-4-11(16)12(17)6-8/h2,4,6,9-10,13-14H,3,5,7H2,1H3/t9-,10+,13+,14-/m0/s1
  • Key:DHXANQGCRAVCSQ-PJQZNRQZSA-N
  (verify)

Tropoxane (O-1072)[1] is an aryloxytropane derivative drug developed byOrganix Inc.,[2] which acts as astimulant and potentdopamine andserotoninreuptake inhibitor. It is an analogue ofdichloropane where theamine nitrogen has been replaced by an oxygenether link (at the bridgehead position), demonstrating that the amine nitrogen is not required forDAT binding and reuptake inhibition.[3][4][5]

Thia analog

[edit]

The 8-thiabicyclo(3.2.1)octanes analogs such asO-4210 have been prepared.[6] A representative set of analogs is listed below.

MAT IC50 (nM) 8-thiabicyclo[3.2.1]octanes
XComDATSERTComDATSERTComDATSERT
H1a910>10uM2a140>8uM3a117>3uM
F1b220>30uM2b59>11uM3b38494
Cl1c13>10uM2c111uM3c9.633
Br1d9.1>25uM2d6.03423d6.014
I1e6.7>8uM2e9.0703e1410
Cl21f4.5>3uM2f6.9993f5.78.0
BN1g8.0>1uM2g8.0363g1613

It had been hypothesized that transporter binding of the tropanes might includeionic bonding of the central tropane nitrogen. But it turned out that at this site neither ionic norhydrogen bonding is a prerequisite for potent monoamine reuptake inhibition. Oxa- and thia-analogs of RTI-111 are potent inhibitors, and even anN-replacement bymethylene holds the potency within the same magnitude.[6][7][8] However,N-quaternisation (N-dimethyl) considerably reduces DAT affinity.

In this SAR, the focus is on seeing the effect of changing 8-NMe to S, O, or CH2. Both enantiomers, as well as the racemates are presented in several cases for comparison.

MAT IC50 (nM) Cl2 bicyclo[3.2.1]octanes
Enant.XComDATSERTComDATSERTComDATSERT
RacS1a4.53,6002a6.9993a5.78.0
RacO1a106,0002a3.164.53a3.36.5
1RNMe1a1.28672a0.4273a1.12.5
RacCH21a7.15,1602a131663a9.633

See also

[edit]

References

[edit]
  1. ^Meltzer PC, Blundell P, Chen Z, Yong YF, Madras BK (March 1999). "Bicyclo[3.2.1]octanes: synthesis and inhibition of binding at the dopamine and serotonin transporters".Bioorganic & Medicinal Chemistry Letters.9 (6):857–62.doi:10.1016/s0960-894x(99)00098-0.PMID 10206550.
  2. ^WO application 9740859, Madras BK, Meltzer PC, "Bridge-substituted Tropanes and Uses", published 6 November 1997, assigned to Harvard College 
  3. ^Madras BK, Pristupa ZB, Niznik HB, Liang AY, Blundell P, Gonzalez MD, Meltzer PC (December 1996). "Nitrogen-based drugs are not essential for blockade of monoamine transporters".Synapse.24 (4):340–8.doi:10.1002/(SICI)1098-2396(199612)24:4<340::AID-SYN4>3.0.CO;2-D.PMID 10638825.S2CID 13410912.
  4. ^Meltzer PC, Liang AY, Blundell P, Gonzalez MD, Chen Z, George C, Madras BK (August 1997). "2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters".Journal of Medicinal Chemistry.40 (17):2661–73.doi:10.1021/jm9703045.PMID 9276012.
  5. ^Madras BK, Miller GM, Meltzer PC, Brownell AL, Fischman AJ (July 2000). "Molecular and regional targets of cocaine in primate brain: liberation from prosaic views".Addiction Biology.5 (3):351–9.doi:10.1111/j.1369-1600.2000.tb00202.x.PMID 20575852.S2CID 26252206.
  6. ^abPham-Huu DP, Deschamps JR, Liu S, Madras BK, Meltzer PC (January 2007)."Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters".Bioorganic & Medicinal Chemistry.15 (2):1067–82.doi:10.1016/j.bmc.2006.10.016.PMC 1829488.PMID 17070057.
  7. ^Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ (October 2003). "Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors".European Journal of Pharmacology.479 (1–3):41–51.doi:10.1016/j.ejphar.2003.08.055.PMID 14612136.
  8. ^Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK (December 2001). "Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?".Synapse.42 (3). New York, N.Y.:129–40.doi:10.1002/syn.1108.PMID 11746710.S2CID 22341553.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
2-Carboxymethyl Esters
(3,4-Disubstituted Phenyl)-tropanes
Arylcarboxy
Carboxyalkyl
Acyl
β,α Stereochemistry
α,β Stereochemistry
Heterocycles: 3-Substituted-isoxazol-5-yl
Heterocycles: 3-Substituted-1,2,4-oxadiazole
N-alkyl
N-replaced (S,O,C)
Irreversible
Nortropanes (N-demethylated)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Tropoxane&oldid=1302650079"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp